Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms

In gliomas, casein kinase 2 (CK2) plays a dominant role in cell survival and tumour invasiveness and is upregulated in many brain tumours. Among CK2 inhibitors, benzimidazole and isothiourea derivatives hold a dominant position. While targeting glioma tumour cells, they show limited toxicity towards...

Descripción completa

Detalles Bibliográficos
Autores principales: Pucko, Emanuela B., Ostrowski, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877581/
https://www.ncbi.nlm.nih.gov/pubmed/35214064
http://dx.doi.org/10.3390/pharmaceutics14020331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877581/
https://www.ncbi.nlm.nih.gov/pubmed/35214064
http://dx.doi.org/10.3390/pharmaceutics14020331

Ejemplares similares